The Centers for Medicare and Medicaid Services (CMS) released a fact sheet detailing the factors the agency will consider when developing an initial offer under the Medicare Drug Price Negotiation Program. CMS explains that it will consider the following information, data, and evidence when developing an initial offer: Evidence about alternative treatments, as available, including: The extent to which the selected drug… (Slifer, September 11, 2023) #Medicare Part D, #Prescription Drugs